Orexigen, FDA agree on trial design for obesity drug

Germany, holding up better than its eurozone partners in the current debt crisis, is battling the increasingly widespread phenomenon of “burnout” which it says is costing its economy billions of euros (dollars) each year.

You can skip to the end and leave a response. Pinging is currently not allowed.

Leave a Reply

Powered by WordPress | Designed by: Premium WordPress Themes | Thanks to Themes Gallery, Bromoney and Wordpress Themes